The EPIC-Norfolk Study

 

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention.

Hoogeveen RM, Pereira JPB, Nurmohamed NS, Zampoleri V, Bom MJ, Baragetti A, Boekholdt SM, Knaapen P, Khaw KT, Wareham NJ, Groen AK, Catapano AL, Koenig W, Levin E, and Stroes ESG

European heart journal. Nov 2019

(DOI : 10.1093/eurheartj/ehaa648)

---

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.

Vaessen SF, Schaap FG, Kuivenhoven JA, Groen AK, Hutten BA, Boekholdt SM, Hattori H, Sandhu MS, Bingham SA, Luben R, Palmen JA, Wareham NJ, Humphries SE, Kastelein JJ, Talmud PJ, and Khaw KT

Journal of lipid research. Jun 2006

(DOI : 10.1194/jlr.M600233-JLR200)

---